Zhejiang Autocon Pharmaceutical Group

Zhejiang Autocon Pharmaceutical Group Co., Ltd., formerly known as Jinhua 71 Pharmaceutical Factory, is a comprehensive pharmaceutical company based in Jinhua, Zhejiang, China. Founded in 1965, the company specializes in the research, development, manufacturing, and sales of chemical active pharmaceutical ingredients (APIs), chemical drug preparations, traditional Chinese medicines, and biological products. Its commercial portfolio includes key products such as Flumazenil, Escitalopram Oxalate, and Azithromycin, targeting therapeutic areas like the central nervous system, anti-infectives, and bone metabolism. Since late 2021, the company's operations have been managed under a trust agreement by Jinhua Conba Bio-pharmaceutical, a subsidiary of the Conba Group, following its acquisition by the Zhejiang Traditional Chinese Medicine and Health Industry Group.